Fortis Healthcare Limited FII & DII Activity

Today's Institutional Flow

On October 28, 2026, foreign institutional investors (FII) record a cash inflow of ₹871.83 cr while domestic institutional investors (DII) post a cash inflow of ₹643.35 cr, together delivering a combined net cash addition of roughly ₹1,515.18 cr to Fortis Healthcare Limited. The simultaneous participation of both investor classes indicates a broadly supportive stance, with the FII contribution alone surpassing the DII figure by about ₹228.48 cr. Overall, today's cash flows represent a sizeable positive deviation from the recent trend, lifting the stock’s liquidity profile and is likely to support near‑term price stability amid ongoing market volatility.

Trend vs 5-Day Average

This stands in stark contrast to the five‑day FII average of –₹894.74 cr, which had been net selling, whereas the DII five‑day average of +₹2,592.03 cr suggests a comparatively muted domestic enthusiasm relative to its longer‑term pace and signals a possible shift in foreign capital flows toward growth‑oriented equities.

F&O Positioning Data

FII futures‑and‑options positioning shows a net long exposure of ₹643,395 cr, underscoring a bullish tilt in derivative contracts. This large derivative stake often precedes increased equity buying as investors hedge. Meanwhile, the index futures long‑short ratio of 1.2 indicates that for every short position, there are 1.2 long positions, reflecting a modest net long bias across the market index.

Healthcare Sector Flow

The healthcare sector has recently attracted net buying from both FIIs and DIIs, reinforcing the positive sentiment surrounding pharmaceutical and hospital stocks.